Breaking: After Outrage Pharmaceutical Exec Now Says He’ll Drop AIDS Drug Price – Won’t Say How Much
A pharmaceutical start up looking to make big money with a 62-year old drug whose price they raised 5500% now says they’ll drop the price. But by how much?
Daraprim, a decades-old pharmaceutical used to help AIDS and cancer patients with life-threatening parasitic infections jumped in price from $13 a pill to $750 a pill when the rights to the drug were sold to a start up run by a former hedge fund manager.
After the New York Times ran a story about the 5500% price-gouging, and Democratic presidential candidate Hillary Clinton tweeted about it – causing pharmaceutical companies’ stock prices to take a dive – the nation grew outraged.
Martin Shkreli, the founder of Turning Pharmaceuticals and a former hedge fund manager who reportedly took a similar tact with another drug, scalping needy patients, refused to cut the price back to $13, promising all week he would not budge, as you can see in the interview above.
But minutes ago Shkreli announced he would respond to public pressure and drop the price, but he has refused to state yet how much.
In response, Hillary Clinton offered this tweet:
Good. https://t.co/UkOr0vfeHX
— Hillary Clinton (@HillaryClinton) September 22, 2015
UPDATE I: 7:38 PM EDT –
Below is a letter dated Monday. Sept. 21, from Sen. Bernie Sanders and Rep. Elijah Cummings to Turing notifying the company they will investigate the price increase. Â
Â
This article has been updated with a newer news video.Â
Thanks to reader Christopher Rioux for the Sanders/Cummings letter.
Image: Screenshot via CNBCÂ
Enjoy this piece?
… then let us make a small request. The New Civil Rights Movement depends on readers like you to meet our ongoing expenses and continue producing quality progressive journalism. Three Silicon Valley giants consume 70 percent of all online advertising dollars, so we need your help to continue doing what we do.
NCRM is independent. You won’t find mainstream media bias here. From unflinching coverage of religious extremism, to spotlighting efforts to roll back our rights, NCRM continues to speak truth to power. America needs independent voices like NCRM to be sure no one is forgotten.
Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure NCRM remains independent long into the future. Support progressive journalism with a one-time contribution to NCRM, or click here to become a subscriber. Thank you. Click here to donate by check.